- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03780738
A Validation Study of The Relationship Between ALDH2 and Aortic Dissection (VaRALAD)
December 18, 2018 updated by: Qilu Hospital of Shandong University
The purpose of this study is to validate the impact of ALDH2 Glu504Lys polymorphism on aortic dissection.
Study Overview
Status
Unknown
Conditions
Study Type
Observational
Enrollment (Anticipated)
200
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Xiao Li
- Phone Number: +8618560088301
- Email: jfm3145496@163.com
Study Locations
-
-
Guangdong
-
Guanzhou, Guangdong, China, 510080
- Recruiting
- Guangdong Provincial People's Hospital
-
Contact:
- Li Xiao
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients diagnosed with aortic dissection in Guangdong Provincial People's Hospital
Description
Inclusion Criteria:
- Chinese Han people diagnosed with aortic dissection in Guangdong Provincial People's Hospital
Exclusion Criteria:
- Aortic dissection based on trauma, connective tissue diseases and pregnancy
- Patients with tumor
- Patients with no written consensus
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Control
Chinese Han people to do physical examination in physical examination center of Guangdong Provincial People's Hospital
|
Aortic dissection
Chinese Han people diagnosed with aortic dissection in Guangdong Provincial People's Hospital
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of patients with different ALDH2 genotype
Time Frame: 1-30 days after samples collected
|
DNA was extracted from venous blood;genomic DNA underwent PCR amplification; finally, PCR products were purified and directly sequenced by Invitrogen Corp or Biosune Corp.Then ALDH2 genotype was distinguished depend on a G-to-A missense mutation on exon 12 of ALDH2 gene.
|
1-30 days after samples collected
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2018
Primary Completion (Anticipated)
September 30, 2019
Study Completion (Anticipated)
September 30, 2019
Study Registration Dates
First Submitted
December 18, 2018
First Submitted That Met QC Criteria
December 18, 2018
First Posted (Actual)
December 19, 2018
Study Record Updates
Last Update Posted (Actual)
December 19, 2018
Last Update Submitted That Met QC Criteria
December 18, 2018
Last Verified
August 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2018GDSRMvalidation
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aortic Dissection
-
Centre Cardiologique du NordUniversita degli Studi di Genova; Henri Mondor University Hospital; Pitié-Salpêtrière...Enrolling by invitationAortic Valve Insufficiency | Aortic Diseases | Ascending Aortic Dissection | Aortic Arch | Aortic Root Dissection | Aortic Root Dilatation | Type A Aortic DissectionFrance
-
Assiut UniversityRecruitingAortic Root Aneurysm | Aortic Root DissectionEgypt
-
The University of Texas Health Science Center,...RecruitingACute Uncomplicated Type b Aortic Dissection: Endovascular Repair vs. Best Medical Therapy (ACUTE-B)Distal Aortic Dissection | Dissection, Aortic Acute | Acute Type B Aortic Dissection (Uncomplicated)United States
-
Petrovsky National Research Centre of SurgeryRecruitingThoracic Aortic Aneurysm | Thoracic Aortic Dissection | Cardiac Valve Disease | Aortic Aneurysm and DissectionRussian Federation
-
University of PennsylvaniaBolton MedicalEnrolling by invitationThoracic Aortic Aneurysm | Thoracic Aortic Dissection | MicroemboliUnited States
-
Braile Biomedica Ind. Com. e Repr. Ltda.RecruitingThoracic Aortic DissectionBrazil
-
The University of Texas Health Science Center,...Washington University School of Medicine; University of Michigan; John Ritter...Active, not recruiting
-
IRCCS San RaffaeleNot yet recruitingAneurysm | Aortic Arch | Dissection, Aortic
-
Hangzhou Endonom Medtech Co., Ltd.RecruitingAortic Aneurysm and DissectionChina
-
Xiaotong HouNot yet recruitingAcute Aortic DissectionChina